Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Clinical trial NCT03320330 · COMPLETED

Trial details

NCT number: NCT03320330
Sponsor: Children's Oncology Group
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Malignant Solid Neoplasm Recurrent Osteosarcoma Refractory Malignant Solid Neoplasm Refractory Osteosarcoma

Start date: 2018-01-31
Primary completion: 2020-12-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.